Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating fatty acid metabolites in the serum of psoriatic arthritis patients using solid-phase microextraction – liquid chromatography – high-resolution mass spectrometry

EF 2020-21

Résumé
Psoriasis is a common inflammatory skin disease that affects more than 1.25 million Canadians. Many patients with psoriasis also develop an inflammatory arthritis called psoriatic arthritis (PsA) that affects their joints. These patients suffer from flaky, red, itchy skin and joint damage leading to reduced quality of life and functional capacity. It is important that clinicians are able to accurately assess the activity of a patient's psoriatic arthritis so that appropriate treatment can be initiated quickly to prevent joint damage. It is very difficult to assess PsA disease activity because each patient presents with a wide array of symptoms. Current methods of assessing disease activity are subjective and imprecise. A previous study looking at small molecules (metabolites) in PsA patients found that certain lipids may be able to differentiate patients based on mild, moderate and severe disease activity. The purpose of this study is to validate these potential biomarkers and determine if they correlate well with joint, skin and overall disease activity. We will test blood samples collected from patients with psoriatic arthritis who have been assessed using three separate activity measurements: ultrasound scan of their joints, severity of skin psoriasis and overall patient and physician scores. We will determine if the lipids in the blood are associated with these three clinical scores. This study will confirm previously identified small molecules and will further our understanding of metabolic pathways in PsA patients. Our future goal is to be able to translate the biomarkers we find into a clinical assessment that can be used to accurately measure disease activity and give clinicians the insight to make better treatment decisions.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449663
Name
Koussiouris John
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating fatty acid metabolites in the serum of psoriatic arthritis patients using solid-phase microextraction – liquid chromatography – high-resolution mass spectrometry
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Lipidomics; Liquid Chromatography; Mass Spectrometry; Metabolomics; Musculoskeletal Health; Psoriasis; Psoriatic Arthritis; Solid-Phase Microextraction; Spondyloarthritis
Abstract
Psoriasis is a common inflammatory skin disease that affects more than 1.25 million Canadians. Many patients with psoriasis also develop an inflammatory arthritis called psoriatic arthritis (PsA) that affects their joints. These patients suffer from flaky, red, itchy skin and joint damage leading to reduced quality of life and functional capacity. It is important that clinicians are able to accurately assess the activity of a patient's psoriatic arthritis so that appropriate treatment can be initiated quickly to prevent joint damage. It is very difficult to assess PsA disease activity because each patient presents with a wide array of symptoms. Current methods of assessing disease activity are subjective and imprecise. A previous study looking at small molecules (metabolites) in PsA patients found that certain lipids may be able to differentiate patients based on mild, moderate and severe disease activity. The purpose of this study is to validate these potential biomarkers and determine if they correlate well with joint, skin and overall disease activity. We will test blood samples collected from patients with psoriatic arthritis who have been assessed using three separate activity measurements: ultrasound scan of their joints, severity of skin psoriasis and overall patient and physician scores. We will determine if the lipids in the blood are associated with these three clinical scores. This study will confirm previously identified small molecules and will further our understanding of metabolic pathways in PsA patients. Our future goal is to be able to translate the biomarkers we find into a clinical assessment that can be used to accurately measure disease activity and give clinicians the insight to make better treatment decisions.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Koussiouris, John
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~